Joost C. Beusekamp

Randomized, Double-Blind, Placebo-Controlled, Multicentre Pilot Study on the Effects of Empagliflozin on Clinical Outcomes in Patients with Acute Decompensated Heart Failure (EMPA-RESPONSE-AHF)

Kevin Damman, Joost C. Beusekamp, Eva M. Boorsma et al. · European Journal of Heart Failure · 2020 · 447 citations · Full text

Medicine, Cardiology, Pharmacology +15

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure

Eva M. Boorsma, Joost C. Beusekamp, Jozine M. ter Maaten et al. · European Journal of Heart Failure · 2020 · 148 citations · Full text

Medicine, Cardiology, Pharmacology +16

Potassium and the Use of Renin–Angiotensin–Aldosterone System Inhibitors in Heart Failure with Reduced Ejection Fraction: Data from BIOSTAT-CHF

Joost C. Beusekamp, Jasper Tromp, Haye H. van der Wal et al. · European Journal of Heart Failure · 2018 · 69 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality

Joost C. Beusekamp, Jasper Tromp, John G.F. Cleland et al. · JACC Heart Failure · 2019 · 44 citations · Full text

Medicine, Cardiology, Pharmacology +9

Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the <scp>REPORT‐HF</scp> registry

Jasper Tromp, Joost C. Beusekamp, Wouter Ouwerkerk et al. · European Journal of Heart Failure · 2022 · 38 citations · Full text

Medicine, Cardiology, Internal Medicine +6